Drug switching in the Netherlands: a cohort study of 20 active substances

BACKGROUND: For a patient, drug switches are not desirable (either between a brand-name drug and a generic drug, or between two generic drugs of the same active substance). Research into the causes of drug switches, and related adverse drug reactions, is hampered by the absence of quantitative data...

Descripción completa

Detalles Bibliográficos
Autores principales: Glerum, Pieter J., Maliepaard, Marc, de Valk, Vincent, Burger, David M., Neef, Kees
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359503/
https://www.ncbi.nlm.nih.gov/pubmed/32660480
http://dx.doi.org/10.1186/s12913-020-05494-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359503/
https://www.ncbi.nlm.nih.gov/pubmed/32660480
http://dx.doi.org/10.1186/s12913-020-05494-x

Ejemplares similares